Share / Export Citation / Email / Print / Text size:

Postępy Mikrobiologii - Advancements of Microbiology

Polish Society of Microbiologists

Subject: Microbiology


ISSN: 0079-4252
eISSN: 2545-3149





Volume / Issue / page

Related articles

VOLUME 56 , ISSUE 3 (April 2017) > List of articles


Dominika Grondalska * / Wioletta Kmieciak

Keywords : Candida auris, fungemia, candidiasis

Citation Information : Postępy Mikrobiologii - Advancements of Microbiology. Volume 56, Issue 3, Pages 282-288, DOI:

License : (CC BY-NC-ND 4.0)

Published Online: 22-May-2019



In recent years, the incoming information about the emergence of new superbacteria and superviruses has been causing growing anxiety. However, also fungi are with increasing frequency reported as the sources of intercontinental microbiological hazards. According to the latest reports, quickly spreading, multidrug-resistant and difficult to identify yeast Candida auris may soon become the center of attention for clinicians, laboratory diagnosticians and the groups of advisers on the hospital-acquired infections, also in Poland. Unfortunately, the methods employed in routine microbiological diagnostics in the Polish medical laboratories cannot reliably identify this dangerous species. It is, therefore, necessary to implement measures to develop this field.

Content not available PDF Share



1. API 20c AUX, bioMerieux, instrukcja zestawu do identyfikacji drożdżaków (2007)

2. Ben-Ami R., Giladi M. i wsp.: Antibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infection. Antimicrob. Agents Chemother. 56, 2518–2523 (2012)

3. Britz E., Govender N.P.: Global emergence of a multi-drug resistant fungal pathogen. South. African J. Infect. Dis. 31, 69–70 (2016)

4. Calvo B., Melo A.S.A., Perozo-Mena A., Hernandez M., Francisco E.C., Hagen F., Meis J.F., Colombo A.L.: First report of Candida auris in America: Clinical and microbiological aspects of 18 episodes of candidemia. J. Infect. 73, 369–374 (2016)

5. Cendejas-Bueno E., Kolecka A., Alastruey-Izquiedro A., Theelen B., Groenewald M., Kostrzewa M., Cuenca-Estrella M., Gómez-López A., Boekhout T.: Reclassification of the Candida haemulonii complex as Candida haemulonii (C. haemulonii Group I), C. duobushaemulonii sp. nov. (C. haemulonii Group II), and C. haemulonii var. vulnera var. nov.: Three multiresistant human pathogenic yeasts. J. Clin. Microbiol. 50, 3641–3651 (2012)

6. Centers for Disease Control and Prevention. Candida auris Interim Recommendations for Healthcare Facilities and Laboratories., 08.12.2016, (20.12.2016)

7. Centers for Disease Control and Prevention. Clinical Alert to U.S Healthcare Facilities-June 2016 – Global Emergence of Invasive Infections Caused by the Multidrug-Resistant Yeast Candida auris. 24.06.2016, http// (20.12.2016)

8. Centers for Disease Control and Prevention: Candida auris Questions and Answers. 04.11.2016, http// (20.12.2016)

9. Chang A., Neofytos D., Horn D.: Candidemia in the 21st century. Future Microbiol. 3, 463–472 (2008)

10. Chatterjee S., Alampalli S.V., Nageshan R.K., Chettiar S.T., Joshi S., Tatu U.S.: Draft genome of a commonly misdiagnosed multidrug resistant pathogen Candida auris. BMC Genomics, 16, 686 (2015)

11. Chowdhary A., Meis J. F. i wsp.: Multidrug-resistant endemic clonal strain of Candida auris in India. Eur. J. Clin. Microbiol. Infect. Dis. 33, 919–926 (2014)

12. Czekaj T., Ciszewski M.: Klebsiella pneumoniae NDM – nowa superbakteria. Med. Rodz. 1, 23–27 (2015)

13. De Almeida J. N., Bernard G. i wsp.: Candida haemulonii compex species, Brazil, January 2010-March 2015. Emerg. Infect. Dis. 22, 561–563 (2016)

14. Emara M., Ahmad S., Khan Z., Joseph L., Al-obaid I., Purohit P., Bafna R.: Candida auris candidemia in Kuwait, 2014. Emerg. Infect. Dis. 21, 1091–1092 (2015)

15. Enoch D.A., Yang H., Aliyu S.H. Micallef C.: The changing epidemiology of invasive fungal infections: new threats. Int.
J. Antimicrob. Ag. 27, 3–6 (2006)

16. Fan S., Zhou L., Wu D., Gao X., Pei E., Tianhou W., Yuwei G., Xianzhu X.: A novel highly pathogenic H5N8 avian influenza virus isolated from a wild duck in China. Influenza Other Respi. Viruses, 8, 646–653 (2014)

17. Fauci A.S., Morens D.M.: Zika virus in the Americas – yet another arbovirus threat. N. Engl. J. Med. 363, 1–3 (2010)

18. Ghosh A.K., Paul S., Sood P., Rudramurthy S.M., Rajbanshi A., Jillwin T.J., Chakrabarti A.: Matrix-assisted laser desorption ionization time-of-flight mass spectrometry for the rapid identification of yeasts causing bloodstream infections. Clin. Microbiol. Infect. 21, 372–378 (2015)

19. Girard V., Mailler S., Chetry M., Vidal C., Durand G., Girard V., VanBelkum A., Colombo A.L., Hagen F., Meis J.F., Chowdhary A.: Identification and typing of the emerging pathogen Candida auris by matrix-assisted laser desorption ionisation time of flight mass spectrometry. Mycoses, 59, 535–538 (2016)

20. Ilyicheva T., Abdurashitov M., Durymanov A., Susloparov I., Goncharova N., Kolosova N., Mikheev V., Ryzhikov A.: Herd immunity and fatal cases of influenza among the population exposed to poultry and wild birds in Russian Asia in 2013–2014. J. Med. Virol. 88, 35–44 (2016)

21. Kathuria S., Singh P. K., Sharma C., Prakash A., Masih A., Kumar A., Meis J.F., Chowdhary A.: Multidrug-resistant Candida auris misidentified as Candida haemulonii: Characterization by matrix-assisted laser desorption ionization-time of flight mass spectrometry and DNA sequencing and its antifungal susceptibility profile variability by Vitek 2, CLSI Broth Microdilution, and E-test method. J. Clin. Microbiol. 53, 1823–1830 (2015)

22. Khillan V., Rathore N., Kathuria S., Chowdhary A.: A rare case of breakthrough fungal pericarditis due to fluconazole-resistant Candida auris in a patient with chronic liver disease. JMM Case Reports, 1, 1−5 (2014)

23. Kim M., Ryang D.W. i wsp.: Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features. Clin. Infect. Dis. 48, e57–61 (2009)

24. Kumar D., Banerjee T., Pratap C.B., Tilak R.: Itraconazole-resistant Candida auris with phospholipase, proteinase and hemolysin activity from a case of vulvovaginitis. J. Infect. Dev. Ctries. 9, 435–437 (2015)

25. Kurtzman C. P., Fell J. W., Boekhout T.: Summary of species characteristics (w) The yeasts: a taxonomic study, Elsevier, 2011, s. 223–278

26. Lee W.G., Shin J.H., Uh Y., Kang M.G., Kim S.H., Park K.H., Jang H.: First three reported cases of nosocomial fungemia caused by Candida auris. J. Clin. Microbiol. 49, 3139–3142 (2011)

27. Magobo R.E., Corcoran C., Seetharam S., Govender N.P.: Candida auris – associated candidemia, South Africa. Emerg. Infect. Dis. 20, 1250–1251 (2014)

28. Marchlik W.D., Kurnatowski P.: Grzyby jako czynniki etiologiczne zakażeń szpitalnych. Otolrynoaryngologia, 9, 50–54 (2010)

29. Mimica M.J., Martino M.D.V., Pasternak J.: MALDI-TOF MS in the clinical microbiology laboratory. J. Bras. Patol. Med. Lab. 49, 256–259 (2013)

30. Mochon A.B., Garner O.B., Hindler J.A., Krogstad P., Ward K.W., Lewinski M.A., Rasheed J.K., Anderson K.F., Limbago B.M., Humphries R.M.: New Delhi metallo-β-lactamase (NDM-1)-producing Klebsiella pneumoniae: Case report and laboratory detection strategies. J. Clin. Microbiol. 49, 1667–1670 (2011)

31. Nigar I., Tarafder S., Razzak Khan R., Ahmed S.M.A., Abu Saleh A.: Species identification of Candida isolated from clinical specimens in a teritary care hospital. 9, 20–25 (2016)

32. Oh B.J., Shin J.H., Kim M.N., Sung H., Lee K., Joo M.J., Shin M.G., Suh S.P., Ryang D.W.: Biofilm formation and genotyping of Candida haemulonii, Candida pseudohaemulonii, and a proposed new species (Candida auris) isolates from Korea. Med. Mycol. 49, 98–102 (2011)

33. Prakash A., Sharma C., Singh A., Kumar Singh P., Kumar A., Hagen F., Govender N. P., Colombo A.L., Meis J.F., Chowdhary A.: Evidence of genotypic diversity among Candida auris isolates by multilocus sequence typing, matrix-assisted laser desorption ionization time-of-flight mass spectrometry and amplified fragment length polymorphism. Clin. Microbiol. Infect. 22, e1–9 (2016)

34. Public Health England, Research and analysis – HPR. Candida auris identified in England., 01.07.2016, http// (20.12.2016)

35. Saluja P., Prasad G.S.: Candida rueliae sp. nov. a novel yeast species isolated from flowers of Ruellia sp. (Acanthaceae). FEMS Yeast Res. 8, 660–666 (2008)

36. Satoh K., Makimura K., Hasumi Y., Nishiyama Y., Uchida K., Yamaguchi H.: Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol. Immunol. 53, 41–44 (2009)

37. Sharma C., Kumar N., Meis J.F., Pandey R., Chowdhary A.: Draft genome sequence of a fluconazole-resistant Candida auris strain from a candidemia patient in India. Genome Announc. 3, e00722–715 (2015)

38. Sharma C., Kumar N., Pandey R., Meis J.F., Chowdhary A.: Whole genome sequencing of emerging multidrug resistant Candida auris isolates in India demonstrates low genetic variation. New Microbes New Infect. 13, 77–82 (2016)

39. Spengler J.R., Ervin E.D., Towner J.S., Rollin P.E., Nichol S.T.: Perspectives on West Africa Ebola virus disease outbreak,
2013–2016. Emerg. Infect. Dis. 22, 956–963 (2016)

40. Staniszewska M., Bondaryk M., Kowalska M., Magda U., Łuka M., Ochal Z., Kurzątkowski W.: Patogeneza i leczenie zakażeń Candida spp. Post. Mikrobiol. 53, 229–240 (2014)

41. Traboulsi R, Ghannoum M.A.: Antifungal therapy, CRC Press Book, 2009, s. 278–292

42. Ullmann A.J., Cuenca-Estrella M. i wsp.: ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT). Clin. Microbiol. Infect. 18, 53–67 (2012)

43. Vallabhaneni S., Mody R.K., Walker T., Chiller T.: The global burden of fungal diseases. Infect. Dis. Clin. North Am. 30, 1–11 (2016)

44. Wu J., Liu L., Wang G., Lu J.: One Health in China. Infect. Ecol. Epidemiol. 1, 1–8 (2016)

45. “Zombie” anthrax outbreak in Siberia: How does it kill? 02.08.2016,
-kills-in-siberia.html (20.12.2016)